Data / Form D filings / Cytogel Pharma, LLC
Cytogel Pharma, LLC: Form D filings
Cytogel Pharma, LLC, a pharmaceuticals company in Darien, CT, filed 17 Form D notices with the SEC between 2010 and 2026. The latest, on March 26, 2026, reports an offering of $16 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 THORNDAL CIRCLE, Darien, CT, 06820
- Phone
- (203) 966-9867
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Connecticut
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1491841
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | Amendment | $16,000,000 | $0 | $16,000,000 | 0 | Yet to occur | sec.gov |
| Dec 23, 2025 | Amendment | $1,000,000 | $250,000 | $750,000 | 3 | Oct 14, 2025 | sec.gov |
| Dec 23, 2025 | New notice | $16,000,000 | $0 | $16,000,000 | 0 | Yet to occur | sec.gov |
| Oct 11, 2024 | Amendment | $2,193,276 | $1,763,884 | $429,392 | 18 | Jun 10, 2023 | sec.gov |
| Jul 28, 2023 | New notice | $2,193,276 | $1,653,884 | $539,392 | 15 | Jun 10, 2023 | sec.gov |
| Jul 12, 2022 | New notice | $1,500,000 | $50,000 | $1,450,000 | 1 | Jun 15, 2022 | sec.gov |
| May 21, 2021 | Amendment | $25,000,000 | $956,905 | $24,043,095 | 12 | Sep 27, 2019 | sec.gov |
| Mar 16, 2021 | Amendment | $25,000,000 | $675,355 | $24,324,645 | 10 | Sep 27, 2019 | sec.gov |
| Mar 23, 2020 | Amendment | $25,000,000 | $575,000 | $24,425,000 | 3 | Sep 27, 2019 | sec.gov |
| Sep 30, 2019 | New notice | $25,000,000 | $500,000 | $24,500,000 | 1 | Sep 27, 2019 | sec.gov |
| Mar 12, 2019 | New notice | $200,000 | $100,000 | $100,000 | 3 | Mar 6, 2019 | sec.gov |
| May 31, 2018 | New notice | $3,000,000 | $161,800 | $2,838,200 | 5 | May 31, 2018 | sec.gov |
| Jan 7, 2015 | New notice | $8,000,000 | $2,691,190 | $5,308,810 | 10 | Jan 6, 2015 | sec.gov |
| Mar 20, 2014 | New notice | $1,110,000 | $240,000 | $870,000 | 2 | Mar 20, 2014 | sec.gov |
| Jul 12, 2013 | Amendment | $2,000,000 | $750,000 | $1,250,000 | 6 | Feb 6, 2013 | sec.gov |
| Feb 12, 2013 | New notice | $700,000 | $15,475 | $684,525 | 1 | Feb 6, 2013 | sec.gov |
| May 17, 2010 | New notice | $2,200,000 | $2,200,000 | 7 | May 12, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| C. Dean Maglaris | Executive Officer, Director | The issuer is an LLC; the "director" function is fulfilled by Managers. |
| Jerry P. Leamon | Director | The issuer is an LLC; the "director" function is fulfilled by Managers. |
| Cassandra Klimp | Director | The issuer is an LLC; the "director" function is fulfilled by Managers. |
| Frederick W. Telling | Executive Officer, Director | The issuer is an LLC; the "director" function is fulfilled by Managers. |
| Steven Chrust | Director | The issuer is an LLC; the "director" function is fulfilled by Managers. |
| Michael Ullmann | Director | The issuer is an LLC; the "director" function is fulfilled by Managers. |
| Eric Lang | Director | The issuer is an LLC; the "director" function is fulfilled by Managers. |
| Theodore Maione | Executive Officer | Dr. Maione is the Issuer's Chief Scientific Officer. |
Other pharmaceuticals companies in Connecticut that filed recently
- Thetis Pharmaceuticals LLC $560,300 · Oct 13, 2026
- Inventure, LLC $82,345 · Sep 3, 2026
Every Form D from the week of Mar 23, 2026 · All recent filings in Connecticut · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Cytogel Pharma, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.